TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VTVT

vTv Therapeutics Inc

Healthcare · Biotechnology

31.40$ +3.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns vTv Therapeutics Inc (VTVT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 54.6% of the shares are freely tradable; institutional investors hold 38.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 38.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 39.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 54.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 4Mio.

Largest Shareholders

Institutions

Institutions VTVT
Name Stake (%) Shares Change (%) Date
Samsara BioCapital, LLC 7.55 298,496 +0.0 06/30/2026
Millennium Management LLC 6.83 269,874 +30.8 06/30/2026
FMR Inc 6.59 260,391 -3.1 03/31/2026
Siren, L.L.C. 4.12 163,000 +0.0 03/31/2026
Baker Bros Advisors LP 3.75 148,314 +0.0 03/31/2026
Vanguard Capital Management, LLC 2.75 108,922 +0.0 03/31/2026
Trails Edge Capital Partners, LP 2.15 85,192 -39.0 06/30/2026
Aisling Capital Management LP 1.26 50,000 +0.0 06/30/2026

Funds

Funds VTVT
Name Stake (%) Shares Change (%) Date
Fidelity Select Biotechnology 6.59 260,391 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 1.54 60,763 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?